Montag & Caldwell’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-743,460
Closed -$108M 85
2017
Q3
$108M Sell
743,460
-49,733
-6% -$6.77M 3.34% 13
2017
Q2
$103M Sell
793,193
-284,071
-26% -$34.8M 3.04% 18
2017
Q1
$134M Sell
1,077,264
-305,479
-22% -$36.6M 3.84% 9
2016
Q4
$160M Sell
1,382,743
-220,251
-14% -$24.5M 3.87% 13
2016
Q3
$168M Buy
1,602,994
+402,828
+34% +$43.6M 3.52% 14
2016
Q2
$118M Sell
1,200,166
-54,996
-4% -$5.69M 2.41% 19
2016
Q1
$126M Sell
1,255,162
-555,261
-31% -$57.2M 2.31% 24
2015
Q4
$217M Sell
1,810,423
-89,562
-5% -$10.4M 4% 6
2015
Q3
$206M Buy
1,899,985
+590,643
+45% +$73.3M 3.42% 9
2015
Q2
$152M Buy
+1,309,342
New +$150M 2.15% 27

Other funds holding CELG

Montag & Caldwell's CELG Position: Q4 2017 in Review

Montag & Caldwell sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 743,460 shares — an estimated $108M sold.

Montag & Caldwell first reported a position in CELG in Q2 2015 and held it in 10 quarters. The position peaked at $217M in Q4 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Montag & Caldwell reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Montag & Caldwell sold 743,460 Celgene Corp shares in Q4 2017, an estimated $108M.
  • Montag & Caldwell first reported a position in Celgene Corp in Q2 2015 and held it in 10 quarters.
  • Montag & Caldwell's Celgene Corp position peaked at $217M in Q4 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Montag & Caldwell's 13F filing for Q4 2017, filed 1 Feb 2018.